Copyright
©The Author(s) 2001.
World J Gastroenterol. Aug 15, 2001; 7(4): 587-592
Published online Aug 15, 2001. doi: 10.3748/wjg.v7.i4.587
Published online Aug 15, 2001. doi: 10.3748/wjg.v7.i4.587
Table 3 Maintenance of efficacy (groups A/B)
| Site | n | Restenosis | Restenosis (wk) | |
| n | No. of times | |||
| Esophagus | 81/38 | 15/10 | 20/12 | 12-35/04-17 |
| Stomach, small intestine | 55/21 | 06/04 | 07/05 | 17-42/07-16 |
| Colon, rectum | 19/09 | 02/00 | 02/00 | 26-43/0 |
| Biliary tract | 48/10 | 06/04 | 09/06 | 8-33/05-26 |
| Total | 203/78 | 29 (14.3)/15 (23.1) | 38/23 | 08-43/04-26 |
- Citation: Mao AW, Gao ZD, Xu JY, Yang RJ, Xiao XS, Jiang TH, Jiang WJ. Treatment of malignant digestive tract obstruction by combined intraluminal stent installation and intra-arterial drug infusion. World J Gastroenterol 2001; 7(4): 587-592
- URL: https://www.wjgnet.com/1007-9327/full/v7/i4/587.htm
- DOI: https://dx.doi.org/10.3748/wjg.v7.i4.587